Capital Investment Advisors, LLC Amgen Inc Transaction History

Capital Investment Advisors, LLC

  • $4.79 Billion
  • Q3 2024

A detailed history of Capital Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 31,333 shares of AMGN stock, worth $9.23 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
31,333
Previous 31,915 1.82%
Holding current value
$9.23 Million
Previous $9.97 Million 1.24%
% of portfolio
0.21%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
SELL
$309.38 - $337.38 $180,059 - $196,355
-582 Reduced 1.82%
31,333 $10.1 Million
Q2 2024

Jul 12, 2024
BUY
$262.75 - $319.31 $3,415 - $4,151
13 Added 0.04%
31,915 $9.97 Million
Q1 2024

Apr 15, 2024
SELL
$268.87 - $324.56 $115,882 - $139,885
-431 Reduced 1.33%
31,902 $9.07 Million
Q4 2023

Jan 05, 2024
SELL
$255.7 - $288.46 $151,118 - $170,479
-591 Reduced 1.8%
32,333 $9.31 Million
Q3 2023

Oct 16, 2023
BUY
$218.65 - $271.46 $103,640 - $128,672
474 Added 1.46%
32,924 $8.85 Million
Q2 2023

Jul 11, 2023
BUY
$214.27 - $253.37 $761,515 - $900,476
3,554 Added 12.3%
32,450 $7.2 Million
Q1 2023

Apr 10, 2023
BUY
$225.79 - $275.2 $540,541 - $658,828
2,394 Added 9.03%
28,896 $6.99 Million
Q4 2022

Jan 05, 2023
BUY
$229.03 - $291.01 $618,381 - $785,727
2,700 Added 11.34%
26,502 $6.96 Million
Q3 2022

Oct 05, 2022
BUY
$224.46 - $253.15 $57,237 - $64,553
255 Added 1.08%
23,802 $5.37 Million
Q2 2022

Jul 06, 2022
BUY
$230.71 - $256.74 $167,956 - $186,906
728 Added 3.19%
23,547 $5.73 Million
Q1 2022

Apr 13, 2022
BUY
$219.27 - $242.57 $458,274 - $506,971
2,090 Added 10.08%
22,819 $5.52 Million
Q4 2021

Jan 10, 2022
BUY
$198.88 - $227.6 $903,710 - $1.03 Million
4,544 Added 28.08%
20,729 $4.66 Million
Q3 2021

Oct 13, 2021
BUY
$212.27 - $248.7 $191,892 - $224,824
904 Added 5.92%
16,185 $3.44 Million
Q2 2021

Jul 14, 2021
BUY
$233.58 - $259.14 $6,773 - $7,515
29 Added 0.19%
15,281 $3.73 Million
Q1 2021

Apr 27, 2021
SELL
$221.91 - $258.6 $77,224 - $89,992
-348 Reduced 2.23%
15,252 $3.8 Million
Q4 2020

Jan 21, 2021
SELL
$216.38 - $257.67 $321,107 - $382,382
-1,484 Reduced 8.69%
15,600 $3.59 Million
Q3 2020

Oct 29, 2020
SELL
$234.65 - $260.95 $11.7 Million - $13 Million
-49,867 Reduced 74.48%
17,084 $4.34 Million
Q2 2020

Jul 20, 2020
BUY
$197.81 - $242.74 $267,043 - $327,699
1,350 Added 2.06%
66,951 $15.8 Million
Q1 2020

Apr 13, 2020
BUY
$182.24 - $241.7 $146,703 - $194,568
805 Added 1.24%
65,601 $13.3 Million
Q4 2019

Jan 21, 2020
BUY
$189.21 - $243.2 $50,897 - $65,420
269 Added 0.42%
64,796 $15.6 Million
Q3 2019

Oct 24, 2019
BUY
$174.11 - $208.62 $672,586 - $805,899
3,863 Added 6.37%
64,527 $12.5 Million
Q2 2019

Jul 17, 2019
BUY
$166.7 - $195.41 $5.82 Million - $6.82 Million
34,887 Added 135.34%
60,664 $11.2 Million
Q1 2019

Apr 11, 2019
BUY
$180.87 - $203.88 $385,976 - $435,079
2,134 Added 9.03%
25,777 $4.9 Million
Q4 2018

Jan 17, 2019
BUY
$178.4 - $208.25 $1,962 - $2,290
11 Added 0.05%
23,643 $4.6 Million
Q3 2018

Oct 15, 2018
SELL
$185.29 - $208.89 $87,086 - $98,178
-470 Reduced 1.95%
23,632 $4.9 Million
Q2 2018

Jul 10, 2018
BUY
$166.05 - $186.51 $318,649 - $357,912
1,919 Added 8.65%
24,102 $4.45 Million
Q1 2018

Apr 16, 2018
BUY
$169.43 - $198.0 $185,017 - $216,216
1,092 Added 5.18%
22,183 $3.78 Million
Q4 2017

Jan 17, 2018
SELL
$168.79 - $188.59 $156,805 - $175,200
-929 Reduced 4.22%
21,091 $3.67 Million
Q3 2017

Oct 17, 2017
BUY
$167.29 - $191.0 $3.68 Million - $4.21 Million
22,020
22,020 $4.11 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email